J. Schueller

Gemcitabine (G) plus capecitabine (C) versus G alone in locally advanced or metastatic pancreatic cancer. A randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG)

R. Herrmann, G. Bodoky, Thomas Ruhstaller et al. · Journal of Clinical Oncology · 2005 · 69 citations

Medicine, Oncology, Pharmacology +14

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer

M. Lehnert, K. Mross, J. Schueller et al. · British Journal of Cancer · 1998 · 32 citations · Full text

Medicine, Oncology, Pharmacology +13

A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting

A. A. Fauser, Giorgio Pizzocaro, J. Schueller et al. · Supportive Care in Cancer · 2000 · 25 citations

Medicine, Oncology, Pharmacology +15

Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera

Elisabeth Singer, Michael Gschwantler, Dina Plattner et al. · European Journal of Gastroenterology & Hepatology · 2007 · 19 citations

Medicine, Nuclear Medicine, Radiology +17

Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study

Katharina E. Schmid‐Kubista, Ilse Krebs, Birgit Gruenberger et al. · British Journal of Ophthalmology · 2009 · 18 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16